Skip to main content
Clinical Trials/CTRI/2012/11/003100
CTRI/2012/11/003100Recruiting未知

A single centre study to collect, store and use of Cancer patientâ??s tissue for designing a technology to test the in vitro sensitivity of the drugs in cell lines which are cultured from the biopsy specimen of solid tumors

G Seven SYNERGON Pvt Ltd0 sites100 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • 1.Male and female patients in the age group of 20-80 years
  • 2.Patients with primary, secondary and recurrent solid tumors
  • 3.Patients who are willing to comply with all study requirements
  • 4.Patients willing to give informed consent

Exclusion Criteria

  • 1.Patients who are unlikely to provide tissue for research (e.g., non-cooperative behavior).
  • 2.Patients with known communicable diseases (HIV, Hepatitis, TB etc)
  • 3.Patients who are currently participating or had participated in drug trials of investigational nature in the last 3 months
  • 4.Female subjects demonstrating a positive pregnancy screen.
  • 5.Female subjects who are currently breast-feeding
  • 6.Female subjects with child bearing potential using prohibited contraceptive method (Oral, Injectable or Implantable hormonal agents

Investigators

Sponsor
G Seven SYNERGON Pvt Ltd

Similar Trials